Last edition
News about "cardiovascular diseases "
GAIA AG and Daiichi Sankyo Europe form an exclusive partnership to commercialise lipodia, a digital therapeutic designed to help adults with Hypercholesterolemia adopt sustainable lifestyle changes for improved cardiovascular health.
Cardiovascular Diseases | 07/03/2026 | By News Bureau | 136
Boston Scientific will acquire Penumbra in a USD 14.5 billion cash and stock deal to expand its vascular and neurovascular portfolio, strengthening its position in thrombectomy, stroke, and cardiovascular disease treatment markets.
Cardiovascular Diseases | 17/01/2026 | By News Bureau | 227
Bayer Acquires Zydus Pharma with Full Ownership
Bayer Pharmaceuticals Private Ltd. and Zydus Lifesciences Ltd. have announced the successful conclusion of their joint venture (JV) - Bayer Zydus Pharma Private Ltd. (BZPPL).
Cardiovascular Diseases | 03/05/2024 | By Aishwarya | 1140
Bayer and Evotec to Upgrade Precision Cardiology
Bayer and Evotec have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).
Cardiovascular Diseases | 01/05/2024 | By Aishwarya | 511
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy